GlaxoSmithKline PLC Company Profile (NYSE:GSK)

About GlaxoSmithKline PLC

GlaxoSmithKline PLC logoGlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company's segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals business develops and makes medicines to treat a range of acute and chronic diseases. The Vaccines business develops, produces and distributes over 1.9 million vaccines every day to people across the world. The Consumer Healthcare business develops and markets products in various categories, such as Wellness, Oral health, Nutrition and Skin health. The Pharmaceuticals Research and Development (R&D) focuses on the discovery and development in various areas of research, which include human immunodeficiency virus (HIV) and infectious diseases, oncology, immuno-inflammation, respiratory and rare diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: GSK
  • CUSIP:
Key Metrics:
  • Previous Close: $44.12
  • 50 Day Moving Average: $44.26
  • 200 Day Moving Average: $42.03
  • Trailing P/E Ratio: 2775.62
  • Foreward P/E Ratio: 16.70
  • P/E Growth: 1.71
  • Market Cap: $107.94B
  • Outstanding Shares: 2,430,500,000
  • Beta: 0.82
Additional Links:
Companies Related to GlaxoSmithKline PLC:

Analyst Ratings

Consensus Ratings for GlaxoSmithKline PLC (NYSE:GSK) (?)
Ratings Breakdown: 1 Sell Rating, 10 Hold Ratings, 8 Buy Ratings
Consensus Rating:Hold (Score: 2.37)
Consensus Price Target: $47.75 (7.52% upside)

Analysts' Ratings History for GlaxoSmithKline PLC (NYSE:GSK)
DateFirmActionRatingPrice TargetDetails
8/17/2016Shore CapitalReiterated RatingHoldView Rating Details
8/12/2016ArgusBoost Price TargetBuy$48.00 -> $50.00View Rating Details
8/10/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
8/2/2016Beaufort SecuritiesReiterated RatingBuyView Rating Details
7/31/2016BNP ParibasReiterated RatingNeutralView Rating Details
7/28/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
7/25/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details
7/14/2016Jefferies GroupUpgradeHold -> BuyView Rating Details
6/27/2016Deutsche Bank AGReiterated RatingHoldView Rating Details
6/22/2016Bank of America Corp.Reiterated RatingBuy$48.00View Rating Details
5/26/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
5/5/2016Oddo SecuritiesUpgradeReduce -> BuyView Rating Details
2/26/2016Cantor FitzgeraldInitiated CoverageHoldView Rating Details
2/4/2016Sanford C. BernsteinBoost Price TargetMarket Perform$43.00 -> $45.00View Rating Details
1/27/2016Bryan, Garnier & CoUpgradeNeutral -> BuyView Rating Details
12/21/2015Leerink SwannReiterated RatingMarket Perform$48.00View Rating Details
11/6/2015Morgan StanleyReiterated RatingNeutralView Rating Details
10/31/2015Societe GeneraleReiterated RatingSellView Rating Details
10/20/2015Credit Suisse Group AGUpgradeUnderperform -> NeutralView Rating Details
6/26/2015Liberum CapitalUpgradeSell -> HoldView Rating Details
6/25/2015HSBCInitiated CoverageBuyView Rating Details
5/22/2015Berenberg BankReiterated RatingHoldView Rating Details
4/16/2015Barclays PLCReiterated RatingOverweightView Rating Details
3/30/2015Kepler Capital MarketsReiterated RatingHoldView Rating Details
2/6/2015Panmure GordonReiterated RatingHoldView Rating Details
2/5/2015S&P Equity ResearchDowngradeHoldView Rating Details
1/22/2015New Street ResearchDowngradeReduceView Rating Details
9/19/2014KillikReiterated RatingNeutralView Rating Details
(Data available from 8/24/2014 forward)


Earnings History for GlaxoSmithKline PLC (NYSE:GSK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/3/2016Q415$0.18$0.18$6.28 billion$6.29 billionViewN/AView Earnings Details
10/28/2015Q3$0.60$0.71$6.07 billion$6.13 billionViewN/AView Earnings Details
7/29/2015Q215$0.50$0.53ViewN/AView Earnings Details
5/6/2015Q115$0.55$0.48ViewN/AView Earnings Details
2/4/2015Q414$0.86$0.82$6.14 billion$6.19 billionViewN/AView Earnings Details
10/22/2014Q314$0.79$0.90ViewListenView Earnings Details
7/23/2014Q114$0.71$0.65ViewN/AView Earnings Details
4/30/2014Q413$0.72$0.70ViewN/AView Earnings Details
2/5/2014Q4$0.30$0.30$6.84 billion$6.91 billionViewN/AView Earnings Details
10/23/2013Q313$0.31$10.31 billion$10.09 billionViewN/AView Earnings Details
7/24/2013$0.26$0.26$6.62 billionViewN/AView Earnings Details
4/25/2012$0.29$0.27ViewN/AView Earnings Details
2/7/2012$0.30$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for GlaxoSmithKline PLC (NYSE:GSK)
Current Year EPS Consensus Estimate: $2.55 EPS
Next Year EPS Consensus Estimate: $2.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.50$0.50$0.50
Q2 20162$0.54$0.55$0.55
Q3 20161$0.77$0.77$0.77
Q4 20161$0.65$0.65$0.65
(Data provided by Zacks Investment Research)


Current Dividend Information for GlaxoSmithKline PLC (NYSE:GSK)
Annual Dividend:$1.98
Dividend Yield:4.46%
Payout Ratio:6,600.00% (Based on Trailing 12 Months of Earnings)
77.65% (Based on Current Year Consensus EPS Estimate)
74.44% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:2.50% (3 Year Average)

Dividend History for GlaxoSmithKline PLC (NYSE:GSK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for GlaxoSmithKline PLC (NYSE:GSK)
No insider trades for this company have been tracked by


Latest Headlines for GlaxoSmithKline PLC (NYSE:GSK)
DateHeadline logoIs Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update? (NYSE:GSK) - August 24 at 8:21 AM
News IconStock in Spotlight: Novartis AG (NYSE:NVS), GlaxoSmithKline PLC (NYSE:GSK) - Newburg Press (NYSE:GSK) - August 22 at 5:24 PM logoInside the Performance of Sanofi’s Human Vaccines Segment in 2Q16 (NYSE:GSK) - August 22 at 9:58 AM logoAre these 3 top stocks still mighty income machines? (NYSE:GSK) - August 22 at 9:58 AM logo3 High-Yielding Healthcare Stocks I'm Not Buying (NYSE:GSK) - August 20 at 9:33 AM
News IconStocks Sparking Bullish Stampede across Wall Street- GlaxoSmithKline plc (NYSE:GSK), Sanofi (NYSE:SNY) - Street Wise Report (press release) (blog) (NYSE:GSK) - August 19 at 5:18 PM
News IconIs GlaxoSmithKline plc(NYSE: GSK), a large market cap stock a smart buy? - The Daily Leicester (NYSE:GSK) - August 19 at 5:18 PM logoNow is the perfect time to buy these 3 healthcare stocks! (NYSE:GSK) - August 19 at 8:16 AM
News IconLockheed Martin Corporation (NYSE:LMT) & GlaxoSmithKline plc (NYSE:GSK) Stocks Trending Alert - Money News (press release) (NYSE:GSK) - August 18 at 8:18 AM
News IconHC Stocks Newsbeat: GlaxoSmithKline plc (ADR) (NYSE:GSK), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - share market updates (press release) (NYSE:GSK) - August 18 at 8:18 AM
News IconVacancies: GlaxoSmithKline (GSK) - Customer Service and Logistics Manager (NYSE:GSK) - August 17 at 5:33 PM
News IconLarge Cap Drug Manufacturers – Major: GlaxoSmithKline plc (NYSE:GSK) (NYSE:GSK) - August 17 at 5:33 PM logoInside Sanofi’s Valuation Changes (NYSE:GSK) - August 17 at 5:33 PM
News IconAt GSK, In-House Lawyers Get Paid to Volunteer (NYSE:GSK) - August 16 at 5:29 PM
News IconTop Gainers of the Day: GlaxoSmithKline plc (NYSE:GSK) from Drug Manufacturers – Major (NYSE:GSK) - August 16 at 5:29 PM logoGlaxoSmithKline plc (ADR) (NYSE:GSK) Survive From New Respiratory Molecule Induction? - TCC (NYSE:GSK) - August 16 at 8:40 AM logoGlaxoSmithKline plc (NYSE:GSK) Offers Money Back Guarantees on ... - TCC (NYSE:GSK) - August 16 at 8:40 AM logoIs it time to take profits on GlaxoSmithKline plc and AstraZeneca plc? (NYSE:GSK) - August 16 at 8:40 AM logoGlaxoSmithKline plc (ADR) (GSK) Offers Money Back Guarantees on Rare Pathological Ailments (NYSE:GSK) - August 15 at 5:31 PM logoGlaxoSmithKline Trades Ex-Dividend Wednesday (GSK) - Investopedia (NYSE:GSK) - August 11 at 8:17 AM logoGlaxoSmithKline Trades Ex-Dividend Wednesday (GSK) (NYSE:GSK) - August 10 at 12:46 PM logoGlaxoSmithKline Plc (NYSE:GSK) To Offer Warranty On Strimvelis For Bubble Boy Disease (NYSE:GSK) - August 10 at 12:46 PM
News IconPrice Target in the Spotlight: GlaxoSmithKline plc (NYSE:GSK) - News Oracle (NYSE:GSK) - August 9 at 8:16 AM logoWhat can Google do that GlaxoSmithKline plc cannot? (NYSE:GSK) - August 9 at 8:16 AM
News IconThese Shifting Currents Could Move Dollars Your Way (NYSE:GSK) - August 8 at 5:30 PM
News IconIs GlaxoSmithKline plc (NYSE:GSK), a large market cap stock a smart buy? (NYSE:GSK) - August 8 at 5:30 PM logo[$$] Week in review: August 6 (NYSE:GSK) - August 8 at 10:02 AM logo9 Stocks for the Bank of England's Corporate-Bond Purchases (NYSE:GSK) - August 8 at 10:02 AM
News IconLeading stocks in today’s market: GlaxoSmithKline plc (NYSE:GSK) (NYSE:GSK) - August 5 at 5:27 PM logoExane BNP Paribas reiterated GlaxoSmithKline PLC (LON:GSK) as 'Neutral' With 1560 PT - FTSE News (NYSE:GSK) - August 5 at 8:15 AM logoA guess at what’s behind the Adaptimmune Therapeutics PLC clinical hold (NYSE:GSK) - August 4 at 5:39 PM
News IconUpdate on GlaxoSmithKline plc (NYSE:GSK) for the day (NYSE:GSK) - August 4 at 5:39 PM logoETF’s with exposure to GlaxoSmithKline Plc : August 4, 2016 (NYSE:GSK) - August 4 at 5:39 PM logoGlaxoSmithKline Plc :GSK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NYSE:GSK) - August 3 at 5:39 PM logoHere's Why GlaxoSmithKline's Stock Is Ready to Scale New Heights (NYSE:GSK) - August 3 at 5:39 PM logoWe've Just Found the 'Apple' of Biotechnology (NYSE:GSK) - August 3 at 5:39 PM logoWhy Google's parent company is betting big on electronic implants to treat conditions like diabetes and asthma (NYSE:GSK) - August 3 at 5:39 PM logoIs it too late to buy GlaxoSmithKline plc, Glencore plc and Royal Bank of Scotland Group plc? (NYSE:GSK) - August 3 at 8:26 AM
News IconGSK Nigeria reports N3.7b loss in H1 (NYSE:GSK) - August 2 at 5:35 PM
News IconAlphabet looks to piggyback tiny implants onto body's nerves (NYSE:GSK) - August 2 at 10:07 AM logoHow Did GlaxoSmithKline’s Pharmaceuticals Segment Do in 2Q16? (NYSE:GSK) - August 2 at 10:07 AM logoGlaxoSmithKline plc (ADR)(GSK) and Alphabet Inc (GOOGL) Team Up for Joint Venture (NYSE:GSK) - August 1 at 5:13 PM logoPortfolio Roundup: Humira Helps Buoy AbbVie Shares (NYSE:GSK) - August 1 at 5:13 PM
News IconHC Stocks Watchful: GlaxoSmithKline plc (ADR) (NYSE:GSK) Medivation Inc (NASDAQ:MDVN) - share market updates (press release) (NYSE:GSK) - August 1 at 10:03 AM logoPM Holds Talks With 'FTSE Fraud Squad' (NYSE:GSK) - July 31 at 9:21 AM logoPM May Holds Talks With 'FTSE Fraud Squad' (NYSE:GSK) - July 31 at 8:59 AM logoGlaxoSmithKline Increases Top Line in 2Q16 (NYSE:GSK) - July 30 at 8:40 PM
News IconHow has GlaxoSmithKline plc:(NYSE:GSK) performed recently ... - The Daily Leicester (NYSE:GSK) - July 30 at 8:12 AM logoGlaxoSmithKline : Pharma giant GSK in 110 million Montrose investment (NYSE:GSK) - July 28 at 4:07 PM logoDeutsche Bank recorded (LON:GSK) GlaxoSmithKline PLC, renewing its price target at 1,700GBX earlier today (NYSE:GSK) - July 28 at 4:07 PM


GlaxoSmithKline PLC (NYSE:GSK) Chart for Wednesday, August, 24, 2016

Last Updated on 8/24/2016 by Staff